IBDEI1ZC ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33148,0)
 ;;=F45.20^^146^1620^2
 ;;^UTILITY(U,$J,358.3,33148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33148,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,33148,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,33148,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,33149,0)
 ;;=F45.21^^146^1620^4
 ;;^UTILITY(U,$J,358.3,33149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33149,1,3,0)
 ;;=3^Hypochondriasis
 ;;^UTILITY(U,$J,358.3,33149,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,33149,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,33150,0)
 ;;=F45.29^^146^1620^3
 ;;^UTILITY(U,$J,358.3,33150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33150,1,3,0)
 ;;=3^Hypochondriacal Disorders NEC
 ;;^UTILITY(U,$J,358.3,33150,1,4,0)
 ;;=4^F45.29
 ;;^UTILITY(U,$J,358.3,33150,2)
 ;;=^5003589
 ;;^UTILITY(U,$J,358.3,33151,0)
 ;;=F45.8^^146^1620^9
 ;;^UTILITY(U,$J,358.3,33151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33151,1,3,0)
 ;;=3^Somatoform Disorders NEC
 ;;^UTILITY(U,$J,358.3,33151,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,33151,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,33152,0)
 ;;=F45.41^^146^1620^5
 ;;^UTILITY(U,$J,358.3,33152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33152,1,3,0)
 ;;=3^Pain Disorder Exclusively Related to Psychological Factors
 ;;^UTILITY(U,$J,358.3,33152,1,4,0)
 ;;=4^F45.41
 ;;^UTILITY(U,$J,358.3,33152,2)
 ;;=^5003590
 ;;^UTILITY(U,$J,358.3,33153,0)
 ;;=F45.42^^146^1620^6
 ;;^UTILITY(U,$J,358.3,33153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33153,1,3,0)
 ;;=3^Pain Disorder w/ Related Psychological Factors
 ;;^UTILITY(U,$J,358.3,33153,1,4,0)
 ;;=4^F45.42
 ;;^UTILITY(U,$J,358.3,33153,2)
 ;;=^5003591
 ;;^UTILITY(U,$J,358.3,33154,0)
 ;;=F45.0^^146^1620^7
 ;;^UTILITY(U,$J,358.3,33154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33154,1,3,0)
 ;;=3^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,33154,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,33154,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,33155,0)
 ;;=F45.9^^146^1620^8
 ;;^UTILITY(U,$J,358.3,33155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33155,1,3,0)
 ;;=3^Somatoform Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,33155,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,33155,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,33156,0)
 ;;=F45.1^^146^1620^10
 ;;^UTILITY(U,$J,358.3,33156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33156,1,3,0)
 ;;=3^Undifferntiated Somatoform Disorder
 ;;^UTILITY(U,$J,358.3,33156,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,33156,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,33157,0)
 ;;=90832^^147^1621^1^^^^1
 ;;^UTILITY(U,$J,358.3,33157,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33157,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,33157,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,33158,0)
 ;;=90834^^147^1621^2^^^^1
 ;;^UTILITY(U,$J,358.3,33158,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33158,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,33158,1,3,0)
 ;;=3^Psychotherapy 38-52 min
 ;;^UTILITY(U,$J,358.3,33159,0)
 ;;=90837^^147^1621^3^^^^1
 ;;^UTILITY(U,$J,358.3,33159,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33159,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,33159,1,3,0)
 ;;=3^Psychotherapy 53-89 min
 ;;^UTILITY(U,$J,358.3,33160,0)
 ;;=90853^^147^1621^4^^^^1
 ;;^UTILITY(U,$J,358.3,33160,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33160,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,33160,1,3,0)
 ;;=3^Group Psychotherapy
 ;;^UTILITY(U,$J,358.3,33161,0)
 ;;=90846^^147^1621^5^^^^1
 ;;^UTILITY(U,$J,358.3,33161,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33161,1,2,0)
 ;;=2^90846
 ;;^UTILITY(U,$J,358.3,33161,1,3,0)
 ;;=3^Family Psychotherapy w/o Pt
